William Blair Predicts Astrana Health Q2 Earnings

Astrana Health, Inc. (NASDAQ:ASTH - Free Report) - Research analysts at William Blair issued their Q2 2026 EPS estimates for shares of Astrana Health in a research note issued on Wednesday, July 2nd. William Blair analyst R. Daniels anticipates that the company will earn $0.45 per share for the quarter. The consensus estimate for Astrana Health's current full-year earnings is $1.15 per share. William Blair also issued estimates for Astrana Health's Q3 2026 earnings at $0.46 EPS.

Astrana Health (NASDAQ:ASTH - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.23 by ($0.09). Astrana Health had a return on equity of 4.90% and a net margin of 1.56%. The business had revenue of $620.39 million for the quarter, compared to analysts' expectations of $628.11 million. During the same period in the previous year, the company earned $0.31 earnings per share. Astrana Health's quarterly revenue was up 53.4% on a year-over-year basis.

Several other equities research analysts also recently weighed in on ASTH. Truist Financial cut their target price on shares of Astrana Health from $50.00 to $46.00 and set a "buy" rating on the stock in a research note on Tuesday, March 18th. Barclays initiated coverage on shares of Astrana Health in a research note on Tuesday, April 1st. They set an "equal weight" rating and a $36.00 target price on the stock. Three equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat, Astrana Health has a consensus rating of "Moderate Buy" and an average target price of $53.29.

Astrana Health Stock Down 4.5%

ASTH traded down $1.13 during trading hours on Friday, hitting $24.15. 268,276 shares of the company's stock were exchanged, compared to its average volume of 297,766. Astrana Health has a 12-month low of $23.12 and a 12-month high of $63.20. The firm has a 50 day moving average of $26.52 and a 200 day moving average of $30.63. The firm has a market cap of $1.35 billion, a P/E ratio of 35.11, a price-to-earnings-growth ratio of 1.36 and a beta of 0.84. The company has a current ratio of 1.70, a quick ratio of 1.70 and a debt-to-equity ratio of 0.54.

Institutional Investors Weigh In On Astrana Health

A number of large investors have recently modified their holdings of the company. Vanguard Group Inc. increased its position in shares of Astrana Health by 4.5% in the 1st quarter. Vanguard Group Inc. now owns 4,898,992 shares of the company's stock valued at $151,918,000 after purchasing an additional 213,033 shares during the last quarter. Dimensional Fund Advisors LP grew its position in shares of Astrana Health by 10.7% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,045,540 shares of the company's stock valued at $32,968,000 after buying an additional 101,192 shares during the last quarter. 325 Capital LLC grew its position in shares of Astrana Health by 30.3% in the 4th quarter. 325 Capital LLC now owns 886,916 shares of the company's stock valued at $27,964,000 after buying an additional 206,009 shares during the last quarter. SteelPeak Wealth LLC grew its position in shares of Astrana Health by 4.8% in the 1st quarter. SteelPeak Wealth LLC now owns 568,176 shares of the company's stock valued at $17,619,000 after buying an additional 26,192 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its position in shares of Astrana Health by 6.0% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 499,529 shares of the company's stock valued at $15,490,000 after buying an additional 28,200 shares during the last quarter. 52.77% of the stock is owned by hedge funds and other institutional investors.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.